Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hepatology
Link
https://link.springer.com/content/pdf/10.1007/s12072-021-10157-y.pdf
Reference47 articles.
1. Siddiqui MS, Harrison SA, Abdelmalek MF, Anstee QM, Bedossa P, Castera L, et al. Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science. Hepatology 2018;67(5):2001–2112. https://doi.org/10.1002/hep.29607 (Epub 2018/02/22, PubMed PMID: 29059456; PubMed Central PMCID: PMCPMC5906171)
2. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64(6):1388–1402. https://doi.org/10.1016/j.jhep.2015.11.004 (Epub 2016/04/07, PubMed PMID: 27062661)
3. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67(1):328–357. https://doi.org/10.1002/hep.29367 (Epub 2017/09/29, PubMed PMID: 28714183)
4. Neuschwander-Tetri BA. Non-alcoholic fatty liver disease. BMC Med 2017;15(1):45. https://doi.org/10.1186/s12916-017-0806-8 (Epub 2017/02/28, PubMed PMID: 28241825; PubMed Central PMCID: PMCPMC5330146)
5. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 2013;10(11):686–690. https://doi.org/10.1038/nrgastro.2013.171 (Epub 2013/09/17, PubMed PMID: 24042449)
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Proportion of metabolic syndrome in hepatocellular carcinoma patients with different etiologies: a retrospective study;2023-11-09
2. Metabolic dysfunction: The silenced connection with fatty liver disease;Annals of Hepatology;2023-11
3. Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis;Cureus;2023-08-30
4. Cardiovascular Disease Risk and Statin Use Among Adults with Metabolic Dysfunction Associated Fatty Liver Disease;The American Journal of Medicine;2023-07
5. Letter: for improved prognostic value, use MAFLD;Alimentary Pharmacology & Therapeutics;2023-06-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3